XThis page contains elements that are not optimised for mobile viewing. Click the link below to view the page in desktop mode.
Desktop mode
Mobile version

Reassessment of reimbursement status of medicinal products in ATC-groups A01, A04, C04, C05 and C10

15 February 2007

In connection with the reassessment of the reimbursement status of medicinal products, the Reimbursement Committee discussed the reimbursement status of certain ATC groups at its meeting on 16 January 2007. The ATC groups concerned are:

  • A01, stomatological preparations, and A04, antiemetics and antinauseants (first discussion)
  • C04, peripheral vasodilators, and C05, vasoprotectives (draft for recommendations)
  • C10, lipid modifying agents (consultation replies received).

Via the fact box to the right, you can find material from the meeting.

For further information, please contact the Reimbursement Section, Send an email .

The Danish Medicines Agency, 19 January 2007